| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | -6.4% |
| Cost of Revenue | $725K | +1.3% |
| Gross Profit | $497K | -15.8% |
| R&D Expense | $9.4M | +32.1% |
| SG&A Expense | $8.1M | -24.4% |
| Operating Income | -$18.0M | -3.4% |
| Interest Expense | $1.4M | — |
| Net Income | -$18.8M | -10.5% |
| EPS (Basic) | -$0.90 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.5M | -59.1% |
| Accounts Receivable | $218K | +296.4% |
| Current Assets | $20.3M | -42.7% |
| Total Assets | $27.4M | -35.9% |
| Current Liabilities | $4.9M | +79.8% |
| Total Liabilities | $6.9M | +30.1% |
| Stockholders' Equity | $20.5M | -45.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | -45.0% |
| Capital Expenditures | $569K | +72.4% |
| Investing Cash Flow | -$677K | +93.7% |
| Financing Cash Flow | -$509K | -101.1% |
| Free Cash Flow | -$14.5M | -45.9% |
| +0.0% |
| EPS (Diluted) | -$0.90 | +0.0% |